Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.43 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.31 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.31 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | GLB1 | P16278 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1639951 | 0.94 | MAOA (0.42) | MAOAMAOBALDH1A1GNAI3GNAO1 | |
| SCHEMBL7297284 | 0.92 | MAOA (0.41) | MAOAMAOBALDH1A1GNAI3GNAO1 | |
| Hydroxyamine SCHEMBL27661557 | 0.89 | MAOA (0.39) | MAOAMAOBALDH1A1GNAI3GNAO1 | |
| Benzene SCHEMBL27331265 | 0.88 | MAOB (0.41) | MAOAMAOBALDH1A1GNAI3GNAO1 | |
| SCHEMBL10901450 | 0.88 | — | — | |
| SCHEMBL28092827 | 0.80 | MAOA (0.30) | MAOAMAOB | |
| SCHEMBL21056397 | 0.80 | MAOA (0.30) | MAOAMAOB | |
| SCHEMBL21246962 | 0.80 | MAOA (0.30) | MAOAMAOB | |
| SCHEMBL27537563 | 0.79 | — | — | |
| SCHEMBL2911167 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105228606-A | Composition of alpha-2 adrenergic receptor and sigma receptor ligand | ESTEVE LABOR DR | 2016-01-06 | — | — | CN | claimed |
| WO-2015134790-A1 | SMALL MOLECULE FATTY ACID SYNTHASE INHIBITORS | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2015-09-11 | — | — | WO | disclosed |
| EP-1005458-B1 | CARBOSTYRIL DERIVATIVES FOR INHIBITING SKIN ERYTHEMA AND/OR SKIN PIGMENTATION | OTSUKA PHARMA CO LTD (JP) | 2004-10-13 | — | — | EP | disclosed |
| US-6133264-A | Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2000-10-17 | — | — | US | disclosed |
| EP-1005458-A1 | CARBOSTYRIL DERIVATIVES FOR INHIBITING SKIN ERYTHEMA AND/OR SKIN PIGMENTATION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2000-06-07 | — | — | EP | disclosed |
| WO-1999009011-A1 | CARBOSTYRIL DERIVATIVES FOR INHIBITING SKIN ERYTHEMA AND/OR SKIN PIGMENTATION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1999-02-25 | — | — | WO | disclosed |
| EP-0248854-B1 | NOVEL BISPHOSPHONIC DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND A PHARMACEUTICAL COMPOSITION | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) | 1990-04-25 | — | — | EP | disclosed |
| US-4870063-A | Bisphosphonic acid derivatives, their production and use | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 1989-09-26 | — | — | US | disclosed |
| EP-0248854-A1 | NOVEL BISPHOSPHONIC DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND A PHARMACEUTICAL COMPOSITION. | LEO PHARM PROD LTD (DK) | 1987-12-16 | — | — | EP | disclosed |
| WO-1987003598-A1 | NOVEL BISPHOSPHONIC DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND A PHARMACEUTICAL COMPOSITION | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 1987-06-18 | — | — | WO | disclosed |